Benefits and Burdens of Participation in a Longitudinal Clinical Trial
Emanuel, Ezekiel J.
Journal of Empirical Research on Human Research Ethics 2009 September; 4(3): 89-97
SYSTEMATIC DATA ON THE IMPACT THAT longitudinal clinical trials have on patient participants are needed to ensure that all the risks and potential benefits of participating in clinical research are properly evaluated and disclosed. Recognizing the lack of systematic data on this topic, we surveyed 582 individuals from Argentina, Brazil, and Thailand who were participating in the ESPRIT study, a Phase III randomized trial of interleukin-2 in HIV disease. Respondents were asked about the benefits and burdens of participating in ESPRIT using a self-administered survey. We found that 91% of respondents in the IL-2 treatment arm and 79% in the no IL-2 control arm reported medical benefits from their participation. In addition, 68% in the IL-2 treatment arm and 60% of the no IL-2 controls reported non-medical benefits. Thirteen percent of the IL-2 respondents and 5% of the non-IL2 respondents reported problems with their jobs due to study participation. Given that respondents, including those in the control arm, reported medical and non-medical benefits and burdens from their research participation, investigators and review committees should be aware of and respond to the potential for research participants to experience benefits and burdens that are unrelated to the intervention being tested.
Permanent LinkFind in a Library
Full Text from Publisher
Clinical Trials; Clinical Research; Disease; Investigators; Research; Review; Review Committees; Survey; Human Experimentation Policy Guidelines / Institutional Review Boards; Informed Consent or Human Experimentation; Research on Special Populations; Acquired Immunodeficiency Syndrome or HIV Infection;
Showing items related by title, author, creator and subject.
Wendler, David; Krohmal, Benjamin; Emanuel, Ezekiel J.; Grady, Christine (2008-06-23)BACKGROUND: Clinical research exposes patient participants to unproved methods and research procedures in order to gather generalizable knowledge to benefit others. While some commentators argue that this process inappropriately ...
Smith, William; Grady, Christine; Krohmal, Benjamin; Lazovski, Jaime; Wendler, David (INSIGHT ESPRIT Group, 2011-01-02)Some commentators argue that informed consent for clinical research should be an on-going process, which begins, rather than ends, with participants' initial consent. Lacking, however, are empirical data on whether there ...
Sabik, Lindsay; Pace, Christine A.; Forster-Gertner, Heidi P.; Wendler, David; Bebchuk, Judith D.; Tavel, Jorge A.; McNay, Laura A.; Killen, Jack; Emanuel, Ezekiel J.; Grady, Christine (2005-09)